MedWatch

Eli Lilly to raise millions for green initiatives

By pricing the sustainability bonds, US-based pharmaceutical company Eli Lilly hopes to raise millions for its ESG objectives.

Photo: Mike Blake/REUTERS / X00030

Regardless of whether you call them green, sustainable or ESG bonds – what it comes down to is the same thing: raising money for green initiatives.

That is exactly what Eli Lilly wants to achieve by issuing what they call "sustainability bonds". The US-based company intends to raise USD 600m (DKK 3.8bn) through the pricing of the bonds.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

Further reading

Related articles

Trial banner

Latest news

See all jobs